SMPD1 rs121908299: Understanding Carrier Status
The rs121908299 variant is a specific genetic change in the SMPD1 gene that results in a missense mutation, where the amino acid arginine is replaced by leucine at position 498. This variant is associated with carrier status for Niemann-Pick disease types A and B, which are autosomal recessive lysosomal storage disorders.
What each genotype means
Typical SMPD1 gene profile
This genotype represents the most common sequence at this position in the SMPD1 gene. It is not associated with the carrier status for Niemann-Pick disease types A or B described for this variant.
This is the most common genotype observed across all global populations.
Niemann-Pick disease carrier status
This genotype indicates you carry one copy of the c.1493G>A (p.Arg498Leu) variant in the SMPD1 gene. Research identifies this as a carrier state for Niemann-Pick disease types A and B, which are lysosomal storage disorders; you should discuss the implications of this carrier status with a genetic counselor or your healthcare provider.
This genotype is found at an allele frequency of approximately 0.015 in the Ashkenazi Jewish population, making it more common in this group than in the general global population.
Potential Niemann-Pick disease risk
This genotype indicates you carry two copies of the c.1493G>A (p.Arg498Leu) variant. Because this variant is associated with Niemann-Pick disease types A and B, individuals with this genotype should consult with a medical geneticist or specialist to understand their specific health risks and clinical status.
This genotype is very rare in the general population.
What is the rs121908299 Variant?
The rs121908299 variant, also identified as c.1493G>A (p.Arg498Leu), is a single nucleotide polymorphism located within the SMPD1 gene. In genetics, a missense variant occurs when a single change in the DNA sequence results in the substitution of one amino acid for another in the final protein product. This specific change alters the structure of the acid sphingomyelinase enzyme. Because Niemann-Pick disease types A and B are inherited in an autosomal recessive pattern, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the clinical symptoms of the disease. Individuals who carry only one copy of this variant are generally considered carriers and typically do not exhibit the severe symptoms associated with the condition, though they may pass the variant to their offspring.
The Role of the SMPD1 Gene
The SMPD1 gene provides the essential instructions for the body to produce an enzyme known as acid sphingomyelinase. This enzyme is primarily responsible for breaking down a type of fat called sphingomyelin within lysosomes, which are the recycling centers of the cell. When the SMPD1 gene contains mutations that significantly reduce or eliminate the activity of this enzyme, sphingomyelin cannot be properly processed. Consequently, this fatty substance accumulates to toxic levels within various cells and tissues, particularly in the liver, spleen, lungs, and brain. This cellular buildup is the underlying cause of Niemann-Pick disease types A and B. The severity of the condition often correlates with the amount of residual enzyme activity; variants that allow for some enzyme function often lead to the milder type B, while those causing a complete loss of function are associated with the more severe type A.
Research and Clinical Evidence
Scientific research has established a clear link between mutations in the SMPD1 gene and acid sphingomyelinase deficiency. The rs121908299 variant is recognized in clinical databases as a variant of interest regarding carrier status. However, it is important to note that the clinical impact of any single variant can be complex. While many variants in SMPD1 are well-documented as pathogenic, the evidence strength for specific rare variants can be limited. Researchers use tools like the SMPD1-ZooM algorithm to predict how specific mutations might affect enzyme stability and disease severity. Because this is a recessive condition, the presence of this variant alone does not constitute a diagnosis of Niemann-Pick disease. Clinical interpretation of such variants is usually performed by genetic counselors or medical geneticists who consider the entire genetic profile and family history of the individual.
Population Frequency and Ancestry
Genetic variants are not distributed equally across all human populations. For the SMPD1 gene, certain mutations have been observed at higher frequencies in specific ethnic groups. For instance, in the Ashkenazi Jewish population, specific SMPD1 mutations are responsible for a significant majority of Niemann-Pick disease type A cases. The rs121908299 variant has been noted in population databases like gnomAD with an allele frequency of approximately 0.015 in Ashkenazi Jewish individuals. This frequency indicates that the variant is present but relatively uncommon. Understanding these population-specific patterns is a key component of carrier screening programs, which aim to provide individuals with information about their risk of passing certain genetic conditions to their children.
What This Information Means for You
If you have received information regarding your status for the rs121908299 variant, it is important to understand that this is not a medical diagnosis. Being a carrier for an autosomal recessive condition is common, as most people carry several recessive variants in their genome. This information is primarily used for reproductive planning and family health awareness. If you are concerned about your carrier status or your family history, the most appropriate step is to consult with a board-certified genetic counselor or a medical geneticist. These professionals can help interpret your results in the context of your personal and family health history. They can also discuss the implications for family members and explain the options for further testing if necessary. Always rely on qualified healthcare providers for medical guidance rather than interpreting genetic data in isolation.
How common is this variant?
The rs121908299 variant has an allele frequency of approximately 0.015 in the Ashkenazi Jewish population according to gnomAD data.
Frequently asked questions
What is Niemann-Pick disease?
Niemann-Pick disease is a group of inherited lysosomal storage disorders caused by the inability of the body to properly break down fats, specifically sphingomyelin. This leads to the accumulation of lipids in organs like the liver, spleen, and brain, causing various health complications.
Does having this variant mean I have Niemann-Pick disease?
No, identifying this variant does not mean you have the disease. Niemann-Pick disease is an autosomal recessive condition, meaning it typically requires two pathogenic variants to manifest symptoms.
What should I do if I am a carrier?
If you are identified as a carrier, you may want to speak with a genetic counselor. They can provide context on what this means for your health and your reproductive options.
Is this variant common?
The frequency of this variant varies by ancestry. In the Ashkenazi Jewish population, it has been observed at a frequency of about 1.5%, making it a known but relatively rare variant.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121908299?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SMPD1
Pathogenic missense variant (p.Arg498Leu) associated with Niemann-Pick disease types A and B.
Pathogenic missense variant (p.Leu304Pro) associated with Niemann-Pick disease types A and B.
Pathogenic substitution (p.Arg498Leu) in SMPD1 associated with Niemann-Pick disease type A/B.
Pathogenic missense variant in SMPD1 (p.Arg498Leu) causing severe infantile Niemann-Pick disease type A in homozygous or compound heterozygous individuals.
Single-nucleotide deletion (c.996delC) leading to acid sphingomyelinase deficiency.
Pathogenic missense variant (p.Arg498Leu) causing acid sphingomyelinase deficiency (Niemann-Pick disease type A/B).